Patent details

EP2753603 Title: POLYMORPHIC FORM OF PRIDOPIDINE HYDROCHLORIDE

Basic Information

Publication number:
EP2753603
PCT Application Number:
EP2012067371
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP127558690
PCT Publication Number:
WO2013034622
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
POLYMORPHIC FORM OF PRIDOPIDINE HYDROCHLORIDE
French Title of Invention:
FORME POLYMORPHE DE CHLORHYDRATE DE PRIDOPIDINE
German Title of Invention:
POLYMORPHE FORM VON PRIDOPIDINHYDROCHLORID
SPC Number:

Dates

Filing date:
06/09/2012
Grant date:
21/06/2017
EP Publication Date:
16/07/2014
PCT Publication Date:
14/03/2013
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
21/06/2017
EP B1 Publication Date:
21/06/2017
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
06/09/2017
Expiration date:
06/09/2032
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
21/06/2017
 
 

Name:
Teva Pharmaceuticals International GmbH
Address:
Schlüsselstrasse 12, 8645 Jona, Switzerland (CH)

Inventor

1

Name:
PITTELKOW, Thomas
Address:
Denmark (DK)

2

Name:
SONESSON, Clas
Address:
Sweden (SE)

3

Name:
FRØSTRUP, Brian
Address:
Denmark (DK)

4

Name:
ZIMMERMANN, Anne
Address:
Denmark (DK)

Priority

1

Priority Number:
201170496
Priority Date:
07/09/2011
Priority Country:
Denmark (DK)

2

Priority Number:
201161533550 P
Priority Date:
12/09/2011
Priority Country:
United States (US)

Classification

IPC classification:
A61K 31/445; A61P 25/28; C07D 211/24;

Publication

European Patent Bulletin

Issue number:
201725
Publication date:
21/06/2017
Description:
Grant (B1)

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages
30/01/2018 Outgoing Correspondence 1